Dr. Patrick Christopher Buczynski, MD

Dr. Buczynski practices at The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical.

Dr. Buczynski's NPI, 1154697514, was assigned on March 29, 2012. Dr. Buczynski holds Tennessee license MD59529.

Dr. Buczynski's primary practice is The University of Tennessee Medical Center, at 1924 Alcoa Highway, Knoxville, TN 37920 in Knox County. The practice phone is (865) 305-9000.

Dr. Buczynski's primary practice is The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical. Dr. Buczynski is also affiliated with Covenant Health Parkwest. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Dr. Buczynski to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buczynski practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Buczynski's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Buczynski is licensed in Tennessee.

CMS data shows 841 Medicare services from Dr. Buczynski across 11 procedure codes in 2024, for 245 Medicare patients. Medicare paid $68,773 for them. Every service was in an office.

CMS counts 245 Medicare patients who saw Dr. Buczynski in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buczynski's median patient age at 68, with 48% women.

In 2024, Dr. Buczynski wrote 7,570 Medicare Part D claims for 489 patients. 88% of them were for generic drugs. CMS names the drug for 6,899 of them, across 124 drugs with 11 or more claims each, at $539,904 in total drug cost. In 2023, CMS named 6,296 claims across 118 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Buczynski for performance year 2024, reported through an alternative payment model (APM). Dr. Buczynski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buczynski as offering telehealth.

CMS Open Payments shows 432 general payments to Dr. Buczynski from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $892.